TABLE 2.
Isolation sites and antifungal susceptibility test results for T. inkin isolates analyzed
| Strain | Isolation site | MIC (μg/ml) of:
|
||||
|---|---|---|---|---|---|---|
| AMB | 5FC | FCZ | ITZ | VOR | ||
| CNM-CL-225 | Bone | 0.25 | 32.0 | 2.0 | 0.50 | 0.06 |
| CNM-CL-306 | Urine | 0.12 | 0.25 | 8.0 | 1.0 | 0.50 |
| CNM-CL-696 | Skin | 0.50 | 16.0 | 2.0 | 0.25 | 0.06 |
| CNM-CL-1996 | Urine | 1.0 | >64.0 | 2.0 | 0.25 | 0.12 |
| CNM-CL-3538 | Subcutaneous abscess | 1.0 | >64.0 | 32.0 | 2.0 | 0.50 |
| CNM-CL-3915 | Peritoneal liquid | 0.50 | 32.0 | 1.0 | 0.06 | 0.03 |
| CNM-CL-3916 | Urine | 0.25 | >64.0 | 2.0 | 0.25 | 0.12 |
| CNM-CL-4074 | Urine | 1.0 | 4.0 | 4.0 | 0.12 | 0.12 |
| CNM-CL-4157 | Skin | 0.25 | >64.0 | 1.0 | 0.06 | 0.12 |
| CNM-CL-4518 | Skin | 0.06 | 8.0 | 2.0 | 0.25 | 0.03 |
| CNM-CL-4811 | Blood | 0.06 | 1.0 | 2.0 | 1.0 | 0.25 |